Frangou, Eleni

Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study

d'Arcy, J. L., Coffey, S., Loudon, M. A., Kennedy, A., Pearson-Stuttard, J., Birks, J., Frangou, E., Farmer, A. J., Mant, D., Wilson, J., et al. (2016) · European Heart Journal

Cardiac Valve Diseases and TreatmentsCardiovascular Function and Risk Factors

Cited by 724

Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: A retrospective, pooled biomarker study

Domingo, E., Freeman-Mills, L., Rayner, E., Glaire, M., Briggs, S., Vermeulen, L., Fessler, E., Medema, J. P., Boot, A., Morreau, H., et al. (2016) · The Lancet Gastroenterology & Hepatology

Genetic factors in colorectal cancerColorectal Cancer Treatments and Studies

Cited by 308

Association of cardiovascular risk factors with MRI indices of cerebrovascular structure and function and white matter hyperintensities in young adults

Williamson, W., Lewandowski, A. J., Forkert, N. D., Griffanti, L., Okell, T. W., Betts, J., Boardman, H., Siepmann, T., McKean, D., Huckstep, O., et al. (2018) · JAMA

Cerebrovascular and genetic disordersCardiovascular Health and Disease Prevention

Cited by 143

Evaluation of liraglutide in the treatment of Alzheimer's disease

Edison, P., Femminella, G. D., Ritchie, C. W., Holmes, C., Walker, Z., Ridha, B. H., Raza, S., Livingston, N. R., Nowell, J., Busza, G., et al. (2021) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 73

An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A double-blind, placebo-controlled, randomised crossover proof of concept study

Sen, A., Akinola, M., Tai, X. Y., Symmonds, M., Davis Jones, G., Mura, S., Galloway, J., Hallam, A., Chan, J. Y. C., Koychev, I., et al. (2021) · Trials

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 30